State of Practice on Transcranial MR-Guided Focused Ultrasound: A Report from the ASNR Standards and Guidelines Committee and ACR Commission on Neuroradiology Workgroup

References

1. 1.↵
   1. Lipsman N,
   2. Schwartz ML,
   3. Huang Y, et al

   . MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013;12:462–68 doi:10.1016/S1474-4422(13)70048-6 pmid:23523144

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Chang WS,
   2. Jung HH,
   3. Kweon EJ, et al

   . Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes. J Neurol Neurosurg Psychiatry 2015;86:257–64 doi:10.1136/jnnp-2014-307642 pmid:24876191

   Abstract/FREE Full Text
3. 3.↵
   1. Elias WJ,
   2. Lipsman N,
   3. Ondo WG, et al

   . A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2016;375:730–39 doi:10.1056/NEJMoa1600159 pmid:27557301

   CrossRefPubMed
4. 4.↵
   1. Bing C,
   2. Ladouceur-Wodzak M,
   3. Wanner CR, et al

   . Trans-cranial opening of the blood-brain barrier in targeted regions using a stereotaxic brain atlas and focused ultrasound energy. J Ther Ultrasound 2014;2:13 doi:10.1186/2050-5736-2-13 pmid:25232482

   CrossRefPubMed
5. 5.↵
   1. Bing C,
   2. Hong Y,
   3. Hernandez C, et al

   . Characterization of different bubble formulations for blood-brain barrier opening using a focused ultrasound system with acoustic feedback control. Sci Rep 2018;8:7986 doi:10.1038/s41598-018-26330-7 pmid:29789589

   CrossRefPubMed
6. 6.↵
   1. Cheng B,
   2. Bing C,
   3. Xi Y, et al

   . Influence of nanobubble concentration on blood-brain barrier opening using focused ultrasound under real-time acoustic feedback control. Ultrasound Med Biol 2019;45:2174–87 doi:10.1016/j.ultrasmedbio.2019.03.016 pmid:31072657

   CrossRefPubMed
7. 7.↵
   1. Lapin NA,
   2. Gill K,
   3. Shah BR, et al

   . Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent. Sci Rep 2020;10:16546 doi:10.1038/s41598-020-73312-9 pmid:33024157

   CrossRefPubMed
8. 8.↵
   1. Shah BR,
   2. Bailey RM,
   3. Youssef I, et al

   . Nitrous oxide enhances focused ultrasound mediated delivery of viral gene therapy. bioRxiv July 12, 2021 doi:10.1101/2021.07.11.451978

   CrossRef
9. 9.↵
   1. Hackett EP,
   2. Shah BR,
   3. Cheng B, et al

   . Probing cerebral metabolism with hyperpolarized 13C imaging after opening the blood-brain barrier with focused ultrasound. ACS Chem Neurosci 2021;12:2820–28 doi:10.1021/acschemneuro.1c00197 pmid:34291630

   CrossRefPubMed
10. 10.↵
    1. Baseri B,
    2. Choi JJ,
    3. Tung YS, et al

    . Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol 2010;36:1445–59 doi:10.1016/j.ultrasmedbio.2010.06.005 pmid:20800172

    CrossRefPubMed
11. 11.↵
    1. Burgess A,
    2. Dubey S,
    3. Yeung S, et al

    . Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology 2014;273:736–45 doi:10.1148/radiol.14140245 pmid:25222068

    CrossRefPubMed
12. 12.↵
    1. Cho CF,
    2. Wolfe JM,
    3. Fadzen CM, et al

    . Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 2017;8:15623 doi:10.1038/ncomms15623 pmid:28585535

    CrossRefPubMed
13. 13.↵
    1. Tung YS,
    2. Vlachos F,
    3. Feshitan JA, et al

    . The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice. J Acoust Soc Am 2011;130:3059–67 doi:10.1121/1.3646905 pmid:22087933

    CrossRefPubMed
14. 14.↵
    1. Louis ED,
    2. Ferreira JJ

    . How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord Off Disord 2010;25:534–41 doi:10.1002/mds.22838 pmid:20175185

    CrossRefPubMed
15. 15.↵
    1. Haubenberger D,
    2. Hallett M

    . Essential tremor. N Engl J Med 2018;378:1802–10 doi:10.1056/NEJMcp1707928 pmid:29742376

    CrossRefPubMed
16. 16.↵
    1. Shah BR,
    2. Lehman VT,
    3. Kaufmann TJ, et al

    . Advanced MRI techniques for transcranial high intensity focused ultrasound targeting. Brain J Brain 2020;143:2664–72 doi:10.1093/brain/awaa107 pmid:32537631

    CrossRefPubMed
17. 17.↵
    1. Lehman VT,
    2. Lee KH,
    3. Klassen BT, et al

    . MRI and tractography techniques to localize the ventral intermediate nucleus and dentatorubrothalamic tract for deep brain stimulation and MR-guided focused ultrasound: a narrative review and update. Neurosurg Focus 2020;49:E8 doi:10.3171/2020.4.FOCUS20170 pmid:32610293

    CrossRefPubMed
18. 18.↵
    1. Feltrin FS,
    2. Chopra R,
    3. Pouratian N, et al

    . Four-tract tractography for magnetic resonance guided high intensity focused ultrasound targeting. Brain Commun 2022;4:fcac273 doi:10.1093/braincomms/fcac273

    CrossRef
19. 19.↵
    1. Holcomb JM,
    2. Chopra R,
    3. Feltrin FS, et al

    . Improving tremor response to focused ultrasound thalamotomy. Brain Commun 2023;5:fcad165 doi:10.1093/braincomms/fcad165 pmid:37533544

    CrossRefPubMed
20. 20.↵
    1. Krishna V,
    2. Sammartino F,
    3. Agrawal P, et al

    . Prospective tractography-based targeting for improved safety of focused ultrasound thalamotomy. Neurosurgery 2019;84:160–68 doi:10.1093/neuros/nyy020 pmid:29579287

    CrossRefPubMed
21. 21.↵
    1. Pérez-García C,
    2. López-Frías A,
    3. Arrazola J, et al

    . Four-tract probabilistic tractography technique for target selection in essential tremor treatment with magnetic resonance-guided focused ultrasound. Eur Radiol 2024;34:5156 doi:10.1007/s00330-023-10431-7 pmid:37950079

    CrossRefPubMed
22. 22.↵
    1. Marras C,
    2. Beck JC,
    3. Bower JH, et al

    ; on behalf of the Parkinson’s Foundation P4 Group. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 2018;4:21 doi:10.1038/s41531-018-0058-0 pmid:30003140

    CrossRefPubMed
23. 23.↵
    1. Blauwendraat C,
    2. Reed X,
    3. Krohn L, et al

    . Genetic modifiers of risk and age at onset in GBA-associated Parkinson’s disease and Lewy body dementia. Brain 2020;143:234–48 doi:10.1093/brain/awz350 pmid:31755958

    CrossRefPubMed
24. 24.↵
    1. Odekerken VJJ,
    2. Boel JA,
    3. Schmand BA, et al

    ; NSTAPS Study Group. GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology 2016;86:755–61 doi:10.1212/WNL.0000000000002401 pmid:26819458

    CrossRefPubMed
25. 25.↵
    1. Odekerken VJJ,
    2. van Laar T,
    3. Staal MJ, et al

    . Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37–44 doi:10.1016/S1474-4422(12)70264-8 pmid:23168021

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Mirza S,
    2. Yazdani U,
    3. Dewey R, III., et al

    . Comparison of globus pallidus interna and subthalamic nucleus in deep brain stimulation for Parkinson disease: an institutional experience and review. Parkinsons Dis 2017;2017:3410820 doi:10.1155/2017/3410820

    CrossRefPubMed
27. 27.↵
    1. Martínez-Fernández R,
    2. Máñez-Miró JU,
    3. Rodríguez-Rojas R, et al

    . Randomized trial of focused ultrasound subthalamotomy for Parkinson’s disease. N Engl J Med 2020;383:2501–13 doi:10.1056/NEJMoa2016311 pmid:33369354

    CrossRefPubMed
28. 28.↵
    1. Horisawa S,
    2. Nanke M,
    3. Kawamata T, et al

    . Pallidothalamic tractotomy for Parkinson disease with 1-year follow-up: a case report. World Neurosurg 2019;121:193–95 doi:10.1016/j.wneu.2018.10.055 pmid:30336294

    CrossRefPubMed
29. 29.↵
    1. Gallay MN,
    2. Moser D,
    3. Magara AE, et al

    . Bilateral MR-guided focused ultrasound pallidothalamic tractotomy for Parkinson’s disease with 1-year follow-up. Front Neurol 2021;12:601153 doi:10.3389/fneur.2021.601153 pmid:33633664

    CrossRefPubMed
30. 30.↵
    1. Giordano M,
    2. Caccavella VM,
    3. Zaed I, et al

    . Comparison between deep brain stimulation and magnetic resonance-guided focused ultrasound in the treatment of essential tremor: a systematic review and pooled analysis of functional outcomes. J Neurol Neurosurg Psychiatry 2020;91:1270–78 doi:10.1136/jnnp-2020-323216 pmid:33055140

    Abstract/FREE Full Text
31. 31.↵
    1. Iorio-Morin C,
    2. Yamamoto K,
    3. Sarica C, et al

    . Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial). Mov Disord Off Disord 2021;36:2653–62 doi:10.1002/mds.28716 pmid:34288097

    CrossRefPubMed
32. 32.↵
    1. Giammalva GR,
    2. Maugeri R,
    3. Umana GE, et al

    . DBS, tcMRgFUS, and gamma knife radiosurgery for the treatment of essential tremor: a systematic review on techniques, indications, and current applications. J Neurosurg Sci 2022;66:476–84 doi:10.23736/S0390-5616.22.05524-2 pmid:35301835

    CrossRefPubMed
33. 33.↵
    1. Elias WJ,
    2. Huss D,
    3. Voss T, et al

    . A pilot study of focused ultrasound thalamotomy for essential tremor. New Engl J Med 2018; 369:640–48 doi:10.1056/NEJMoa1300962 pmid:23944301

    CrossRefPubMed
34. 34.↵
    1. Vigen KK,
    2. Reeder SB,
    3. Hood MN, et al

    ; ISMRM Safety Committee. Recommendations for imaging patients with cardiac implantable electronic devices (CIEDs). J Magn Reson Imaging 2021;53:1311–17 doi:10.1002/jmri.27320 pmid:32808391

    CrossRefPubMed
35. 35.↵
    1. Caston RM,
    2. Campbell JM,
    3. Rahimpour S, et al

    . Hemorrhagic safety of magnetic resonance-guided focused ultrasound thalamotomy for tremor without interruption of antiplatelet or anticoagulant therapy. Stereotact Funct Neurosurg 2023;101:314–18 doi:10.1159/000533590 pmid:37690446

    CrossRefPubMed
36. 36.↵
    1. Yuen J,
    2. Goyal A,
    3. Kaufmann TJ, et al

    . Comparison of the impact of skull density ratio with alternative skull metrics on magnetic resonance-guided focused ultrasound thalamotomy for tremor. J Neurosurg 2023;138:50–57 doi:10.3171/2022.5.JNS22350 pmid:35901729

    CrossRefPubMed
37. 37.↵
    1. Jackson LM,
    2. Kaufmann TJ,
    3. Lehman VT, et al

    . Clinical characteristics of patients with gait instability after MR-guided focused ultrasound thalamotomy. Tremor Other Hyperkinet Mov (N Y) 2021;11:41 doi:10.5334/tohm.643 pmid:34721943

    CrossRefPubMed
38. 38.↵
    1. Wintermark M,
    2. Druzgal J,
    3. Huss DS, et al

    . Imaging findings in MR imaging-guided focused ultrasound treatment for patients with essential tremor. AJNR Am J Neuroradiol 2014;35:891–96 doi:10.3174/ajnr.A3808 pmid:24371027

    Abstract/FREE Full Text
39. 39.↵
    1. Ravikumar VK,
    2. Parker JJ,
    3. Hornbeck TS, et al

    . Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor. Mov Disord Off Disord 2017;32:1165–73 doi:10.1002/mds.26997 pmid:28370272

    CrossRefPubMed
40. 40.↵
    1. Lipsman N,
    2. Meng Y,
    3. Bethune AJ, et al

    . Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun 2018;9:2336 doi:10.1038/s41467-018-04529-6 pmid:30046032

    CrossRefPubMed
41. 41.↵
    1. Lavon I,
    2. Refael M,
    3. Zelikovitch B, et al

    . Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. Neuro Oncol 2010;12:173–80 doi:10.1093/neuonc/nop041 pmid:20150384

    CrossRefPubMed
42. 42.↵
    1. Nir L

    . Alzheimer’s FUS Clinical Trial. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02986932.
43. 43.↵
    1. Pacia CP,
    2. Yuan J,
    3. Yue Y, et al

    . Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA. Theranostics 2022;12:362–78 doi:10.7150/thno.65597 pmid:34987650

    CrossRefPubMed
44. 44.↵
    1. Wei HJ,
    2. Upadhyayula PS,
    3. Pouliopoulos AN, et al

    . Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment. Int J Radiat Oncol Biol Phys 2021;110:539–50 doi:10.1016/j.ijrobp.2020.12.019 pmid:33346092

    CrossRefPubMed
45. 45.↵
    1. Stupp R,
    2. Hegi ME,
    3. Mason WP, et al

    ; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459–66 doi:10.1016/S1470-2045(09)70025-7 pmid:19269895

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Liu HL,
    2. Huang CY,
    3. Chen JY, et al

    . Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment. PLoS One 2014;9:e114311 doi:10.1371/journal.pone.0114311 pmid:25490097

    CrossRefPubMed
47. 47.↵
    1. Mahoney JJ,
    2. Thompson-Lake DG,
    3. Ranjan M, et al

    . Low-intensity focused ultrasound targeting the bilateral nucleus accumbens as a potential treatment for substance use disorder: a first-in-human report. Biol Psychiatry 2023;94:e41–43 doi:10.1016/j.biopsych.2023.06.031 pmid:37610405

    CrossRefPubMed
48. 48.↵
    1. Chiu SY,
    2. Nozile-Firth K,
    3. Klassen BT, et al

    . Ataxia and tolerance after thalamic deep brain stimulation for essential tremor. Parkinsonism Relat Disord 2020;80:47–53 doi:10.1016/j.parkreldis.2020.09.009 pmid:32950784

    CrossRefPubMed